Nisa Investment Advisors’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $221 | Hold |
25
| – | – | ﹤0.01% | 2993 |
|
|
2025
Q1 | $269 | Sell |
25
-9
| -26% | -$97 | ﹤0.01% | 2888 |
|
|
2024
Q4 | $438 | Buy |
34
+28
| +467% | +$361 | ﹤0.01% | 2856 |
|
|
2024
Q3 | $164 | Sell |
6
-16
| -73% | -$437 | ﹤0.01% | 2875 |
|
|
2024
Q2 | $638 | Buy |
22
+8
| +57% | +$232 | ﹤0.01% | 2632 |
|
|
2024
Q1 | $622 | Buy |
14
+6
| +75% | +$267 | ﹤0.01% | 2465 |
|
|
2023
Q4 | $297 | Buy |
+8
| New | +$297 | ﹤0.01% | 2497 |
|
|
2023
Q3 | – | Sell |
-266
| Closed | -$16.9K | – | 2809 |
|
|
2023
Q2 | $16.9K | Buy |
+266
| New | +$16.9K | ﹤0.01% | 2145 |
|
|
2023
Q1 | – | Sell |
-7
| Closed | – | – | 2617 |
|
|
2022
Q4 | $0 | Sell |
7
-295
| -98% | – | ﹤0.01% | 2651 |
|
|
2022
Q3 | $36K | Buy |
302
+7
| +2% | +$834 | ﹤0.01% | 1867 |
|
|
2022
Q2 | $38K | Buy |
+295
| New | +$38K | ﹤0.01% | 1825 |
|